Literature DB >> 169801

Rous sarcoma regression in chickens resistant or susceptible to Marek's disease.

B W Calnek, D A Higgins, J Fabricant.   

Abstract

In 4 experiments, strains of chickens relatively susceptible (S-strain, P-line) or resistant (N-line, PDRC) to Marek's disease (MD) were challenged with Rous sarcoma virus (RSV) at 6-8 weeks old. RSV tumors occurred in 94-100% of the birds in each strain, but the number with tumors that regressed during the 40-46-day experiment varied from 7% (S-strain) to 91% (PDRC). The N-line and P-line birds, derived from a random-bred flock with selection only for susceptibility or resistance to MD, regressed their tumors at about equal rates (respectively 59 and 65%). Thus, although the genetic strains differed in ability to regress RSV tumors, the difference was not necessarily related to genetic resistance or susceptibility to MD. Other birds in 2 of the experiments, infected 2-4 weeks earlier with JM or GA isolants of MD virus, had significantly (P less than 0.01) lower incidence of RSV tumor regression than did controls provided that they developed gross lesions of MD.

Entities:  

Mesh:

Year:  1975        PMID: 169801

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  6 in total

1.  Comparative effects of host and viral factors on early pathogenesis of Marek's disease.

Authors:  J Fabricant; M Ianconescu; B W Calnek
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Demyelination in allergic and Marek's disease virus induced neuritis. Comparative electron microscopic studies.

Authors:  P Lampert; R Garrett; H Powell
Journal:  Acta Neuropathol       Date:  1977-10-10       Impact factor: 17.088

3.  Specificity of B genotype response to tumors induced by each of three subgroups of RSV.

Authors:  D W Brown; W M Collins; W E Briles
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Some effects of silical treatment on Marek's disease.

Authors:  D A Higgins; B W Calnek
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

5.  Depression of vaccinal immunity to Marek's disease by infection with reticuloendotheliosis virus.

Authors:  R L Witter; L F Lee; L D Bacon; E J Smith
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  Marek's disease as a model for the Landry--Guillain--Barré syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelin.

Authors:  J S Pepose; J G Stevens; M L Cook; P W Lampert
Journal:  Am J Pathol       Date:  1981-05       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.